Peer-influenced content. Sources you trust. No registration required. This is HCN.
Clinical Advances in Hematology & Oncology
A case-based application of FRESCO trial data positions fruquintinib as a third-line option in KRAS-mutant metastatic colorectal cancer, while emphasizing treatment decisions shift toward disease control and quality of life after multiple prior lines.
Hematology/Oncology July 13th 2026
Ophthalmology Advisor
Primary trabeculectomy reduced the rate of visual field loss by approximately 50% compared with a medications-first approach in newly diagnosed advanced open-angle glaucoma patients across a 5-year randomized trial, though standard quality-of-life instruments failed to detect that clinical benefit.
Ophthalmology June 29th 2026
Sleep-Wake Advisor
More than half of women aged 50–80 reported sleep problems in a cross-sectional survey analysis, with symptomatic menopausal women significantly more likely to be affected than those without menopausal symptoms.
Internal Medicine June 17th 2026
Parkinson’s News Today
Switching Parkinson’s patients to Crexont added more than three hours of daily symptom control in interim Phase 4 data. Here’s how to read an open-label, sponsor-run signal.
Neurology April 30th 2026
MDLinx
Stories from professional golfers with Parkinson’s illustrate how early motor symptoms disrupt precision, identity, and daily activities.
Geriatrics April 15th 2026
Heart
Studies on fluid restriction in patients with HF are scarce, and most of the available studies are at high risk of bias. Although power is lacking, there is no evidence indicating that fluid restriction affects mortality or HF hospitalizations, but there is a signal of harm in terms of thirst distress.
Cardiology March 25th 2026